1. Low incidence of serum neutralizing factors m patients receiving recombinant alpha 2b interferon;Spiegel;Am J Med,1986
2. Recombinant alpha 2a interferon (alpha IFN) in the treatment of essential thrombocythaemia; preliminary report;Gugliotta;Haematologica,1987
3. M. Lazzarino, A. Vitale, E. Morra, et al., Interferon alpha 2b in the treatment of Ph-negative chronic myeloproliferative disorders (CMD) with excessive thrombocytosis (XXIInd Congress of the International Society of Hematology, 1988 abstr PMI-7).
4. H. Kasparu, R. Reisner, M. Bernhart, et al., First results of the treatment of essential thrombocythemia with recombinant alpha 2b interferon (XXIInd Congress of the Intemanonal Society of Hematology, 1988 abstr OPTH10-9).
5. G. Middelhoff, I. Boll, A. Teichman, Ac Mayer, Interferon in chronic myeloproliferative disorders with thrombocytosis: a clinical trial (XXIInd Congress of the International Society of Hematology, 1988 abstr OPTH10-11).